Balaxi Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 9.97 | 14.07 | 22.45 |
| Operating Expense | 10.30 | 11.06 | 19.68 |
| Net Profit | -1.18 | 1.74 | 1.66 |
| Net Profit Margin | -11.84 | 12.37 | 7.39 |
| Earning Per Share | -0.21 | 0.32 | 0.30 |
| EBIDTA | -0.30 | 3.03 | 2.79 |
| Effective Tax Rate | -24.24 | 20.27 | 20.22 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 9.97 |
| Operating Expense | 10.30 |
| Net Profit | -1.18 |
| Net Profit Margin | -11.84 |
| Earning Per Share | -0.21 |
| EBIDTA | -0.30 |
| Effective Tax Rate | -24.24 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 70.20 | 108.14 | 101.29 |
| Operating Expenses Annual | 64.96 | 91.32 | 84.03 |
| Operating Profit Annual | 7.63 | 23.43 | 20.01 |
| Interest Annual | 1.54 | 0.46 | 0.06 |
| Depreciation | 0.51 | 0.52 | 0.25 |
| Net Profit Annual | 3.65 | 16.22 | 14.67 |
| Tax Annual | 1.93 | 6.23 | 5.03 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 70.20 |
| Operating Expenses Annual | 64.96 |
| Operating Profit Annual | 7.63 |
| Interest Annual | 1.54 |
| Depreciation | 0.51 |
| Net Profit Annual | 3.65 |
| Tax Annual | 1.93 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 17.87 | 0.84 | 0.47 |
| Cash Flow from Operations | -1.83 | -7.07 | 8.89 |
| Cash Flow from Investing | 0.47 | -2.29 | -6.87 |
| Cash Flow from Financing | 27.55 | 26.39 | -1.64 |
| Cash Flow at the End | 44.06 | 17.88 | 0.84 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 17.87 |
| Cash Flow from Operations | -1.83 |
| Cash Flow from Investing | 0.47 |
| Cash Flow from Financing | 27.55 |
| Cash Flow at the End | 44.06 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 11.04 | 21.71 | 19.79 |
| PBIT Margin (%) | 10.31 | 21.23 | 19.55 |
| PBT Margin (%) | 4.10 | -20.40 | -175.93 |
| Net PROFIT Margin (%) | 5.20 | 15.00 | 14.48 |
| Return On Networth / Equity (%) | 3.42 | 21.62 | 29 |
| Return On Networth /Employed (%) | 5.99 | 27.93 | 37.15 |
| Return On Assets (%) | 3.02 | 19.80 | 27.52 |
| Total Debt / Equity (X) | 0.13 | 0.10 | 0.05 |
| Asset Turnover Ratio (%) | 0.58 | 1.32 | 1.90 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 11.04 |
| PBIT Margin (%) | 10.31 |
| PBT Margin (%) | 4.10 |
| Net PROFIT Margin (%) | 5.20 |
| Return On Networth / Equity (%) | 3.42 |
| Return On Networth /Employed (%) | 5.99 |
| Return On Assets (%) | 3.02 |
| Total Debt / Equity (X) | 0.13 |
| Asset Turnover Ratio (%) | 0.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 7.10 | 7.89 | 2.20 |
| Total Current Assets Annual | 122.90 | 99.02 | 54.08 |
| Non Current Assets Annual | 31.46 | 30.70 | 27.84 |
| Total Shareholders Funds Annual | 121.55 | 92.11 | 57.91 |
| Total Assets Annual | 154.36 | 129.72 | 81.92 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 7.10 |
| Total Current Assets Annual | 122.90 |
| Non Current Assets Annual | 31.46 |
| Total Shareholders Funds Annual | 121.55 |
| Total Assets Annual | 154.36 |
EPS (INR)
Expected
7.83
Reported
1.56
Surprise
-80.08%
Dec 2024
EPS beaten by -80.08%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 1.20%
